+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Xerostomia Therapeutics Market 2020-2024- Product Image
Global Xerostomia Therapeutics Market 2020-2024- Product Image

Global Xerostomia Therapeutics Market 2020-2024

  • ID: 5174382
  • Report
  • September 2020
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • Apotex Inc.
  • Church & Dwight Co. Inc.
  • Colgate-Palmolive Co.
  • Daiichi Sankyo Co. Ltd.
  • Eisai Co. Ltd.
  • GlaxoSmithKline Plc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Xerostomia Therapeutics Market 2020-2024

The xerostomia therapeutics market is poised to grow by $ 133.27 mn during 2020-2024 progressing at a CAGR of 4% during the forecast period. The report on xerostomia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing awareness of xerostomia and growing geriatric population. In addition, increasing awareness of xerostomia is anticipated to boost the growth of the market as well.

The xerostomia therapeutics market analysis includes product segment and geographical landscapes.

The xerostomia therapeutics market is segmented as below:

By Product
  • OTC
  • Prescription
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the high risk factors for xerostomia as one of the prime reasons driving the xerostomia therapeutics market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The xerostomia therapeutics market covers the following areas:
  • Xerostomia therapeutics market sizing
  • Xerostomia therapeutics market forecast
  • Xerostomia therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading xerostomia therapeutics market vendors that include Apotex Inc., Church & Dwight Co. Inc., Colgate-Palmolive Co., Cumberland Pharmaceuticals Inc., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., GlaxoSmithKline Plc, Pharmascience Inc., Quest Products Inc., and Sun Pharmaceutical Industries Ltd.. Also, the xerostomia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Apotex Inc.
  • Church & Dwight Co. Inc.
  • Colgate-Palmolive Co.
  • Daiichi Sankyo Co. Ltd.
  • Eisai Co. Ltd.
  • GlaxoSmithKline Plc
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • OTC - Market size and forecast 2019-2024
  • Prescription - Market size and forecast 2019-2024
  • Market opportunity by Product
Customer Landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Apotex Inc.
  • Church & Dwight Co. Inc.
  • Colgate-Palmolive Co.
  • Cumberland Pharmaceuticals Inc.
  • Daiichi Sankyo Co. Ltd.
  • Eisai Co. Ltd.
  • GlaxoSmithKline Plc
  • Pharmascience Inc.
  • Quest Products Inc.
  • Sun Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Product - Market share 2019-2024 (%)
22: Comparison by Product
23: OTC - Market size and forecast 2019-2024 ($ million)
24: OTC - Year-over-year growth 2019-2024 (%)
25: Prescription - Market size and forecast 2019-2024 ($ million)
26: Prescription - Year-over-year growth 2019-2024 (%)
27: Market opportunity by Product
28: Customer Landscape
29: Market share by geography 2019-2024 (%)
30: Geographic comparison
31: North America - Market size and forecast 2019-2024 ($ million)
32: North America - Year-over-year growth 2019-2024 (%)
33: Europe - Market size and forecast 2019-2024 ($ million)
34: Europe - Year-over-year growth 2019-2024 (%)
35: Asia - Market size and forecast 2019-2024 ($ million)
36: Asia - Year-over-year growth 2019-2024 (%)
37: ROW - Market size and forecast 2019-2024 ($ million)
38: ROW - Year-over-year growth 2019-2024 (%)
39: Key leading countries
40: Market opportunity by geography ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Apotex Inc. - Overview
48: Apotex Inc. - Product and service
49: Apotex Inc. - Key offerings
50: Apotex Inc. - Key customers
51: Apotex Inc. - Segment focus
52: Church & Dwight Co. Inc. - Overview
53: Church & Dwight Co. Inc. - Business segments
54: Church & Dwight Co. Inc. - Key offerings
55: Church & Dwight Co. Inc. - Key customers
56: Church & Dwight Co. Inc. - Segment focus
57: Colgate-Palmolive Co. - Overview
58: Colgate-Palmolive Co. - Business segments
59: Colgate-Palmolive Co. - Key offerings
60: Colgate-Palmolive Co. - Key customers
61: Colgate-Palmolive Co. - Segment focus
62: Cumberland Pharmaceuticals Inc. - Overview
63: Cumberland Pharmaceuticals Inc. - Business segments
64: Cumberland Pharmaceuticals Inc. - Key offerings
65: Cumberland Pharmaceuticals Inc. - Key customers
66: Cumberland Pharmaceuticals Inc. - Segment focus
67: Daiichi Sankyo Co. Ltd. - Overview
68: Daiichi Sankyo Co. Ltd. - Business segments
69: Daiichi Sankyo Co. Ltd. - Key offerings
70: Daiichi Sankyo Co. Ltd. - Key customers
71: Daiichi Sankyo Co. Ltd. - Segment focus
72: Eisai Co. Ltd. - Overview
73: Eisai Co. Ltd. - Business segments
74: Eisai Co. Ltd. - Key offerings
75: Eisai Co. Ltd. - Key customers
76: Eisai Co. Ltd. - Segment focus
77: GlaxoSmithKline Plc - Overview
78: GlaxoSmithKline Plc - Business segments
79: GlaxoSmithKline Plc - Key offerings
80: GlaxoSmithKline Plc - Key customers
81: GlaxoSmithKline Plc - Segment focus
82: Pharmascience Inc. - Overview
83: Pharmascience Inc. - Product and service
84: Pharmascience Inc. - Key offerings
85: Pharmascience Inc. - Key customers
86: Pharmascience Inc. - Segment focus
87: Quest Products Inc. - Overview
88: Quest Products Inc. - Product and service
89: Quest Products Inc. - Key offerings
90: Quest Products Inc. - Key customers
91: Quest Products Inc. - Segment focus
92: Sun Pharmaceutical Industries Ltd. - Overview
93: Sun Pharmaceutical Industries Ltd. - Business segments
94: Sun Pharmaceutical Industries Ltd. - Key offerings
95: Sun Pharmaceutical Industries Ltd. - Key customers
96: Sun Pharmaceutical Industries Ltd. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Apotex Inc.
  • Church & Dwight Co. Inc.
  • Colgate-Palmolive Co.
  • Daiichi Sankyo Co. Ltd.
  • Eisai Co. Ltd.
  • GlaxoSmithKline Plc
The publisher recognizes the following companies as the key players in the global xerostomia therapeutics market: Apotex Inc., Church & Dwight Co. Inc., Colgate-Palmolive Co., Cumberland Pharmaceuticals Inc., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., GlaxoSmithKline Plc, Pharmascience Inc., Quest Products Inc., and Sun Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is high risk factors for xerostomia."

According to the report, one of the major drivers for this market is the increasing awareness of xerostomia.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Apotex Inc.
  • Church & Dwight Co. Inc.
  • Colgate-Palmolive Co.
  • Cumberland Pharmaceuticals Inc.
  • Daiichi Sankyo Co. Ltd.
  • Eisai Co. Ltd.
  • GlaxoSmithKline Plc
  • Pharmascience Inc.
  • Quest Products Inc.
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll